AKERO THERAPEUTICS INC shareholders Q3 2023

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 188 filers reported holding AKERO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

AKERO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRANKLIN RESOURCES INC 22,892$1,157,8780.00%
SIMPLEX TRADING, LLC 33,582$1,6980.00%
Belvedere Trading LLC 8,500$429,9300.00%
UBS Group AG 58,403$2,954,0230.00%
Caption Management, LLC 1,265$63,9840.00%
AQR Capital Management 10,899$551,2710.00%
WOLVERINE TRADING, LLC 9,900$500,7420.00%
WOLVERINE TRADING, LLC 18,700$945,8460.00%
CITIGROUP INC 6,800$343,9440.00%
Hillsdale Investment Management Inc. 100$5,0580.00%
CWM, LLC 54$30.00%
NISA INVESTMENT ADVISORS, LLC 980$49,5680.00%
US BANCORP \DE\ 2,270$114,8160.00%
AMERIPRISE FINANCIAL INC 20,638$1,043,8700.00%
Daiwa Securities Group Inc. 188$100.00%
STRS OHIO 1,000$500.00%
OSAIC HOLDINGS, INC. 5,242$265,1360.00%
ZRC WEALTH MANAGEMENT, LLC 10$5060.00%
Covestor Ltd 3$00.00%
Belvedere Trading LLC 6,200$313,5960.00%
External links

This page lists AKERO THERAPEUTICS INC's shareholders in Q3 2023. To view AKERO THERAPEUTICS INC's shareholder history, click here.